|
2019 Journal Article Strategies to counter antipsychotic-associated weight gain in patients with schizophreniaMarteene, Wade, Winckel, Karl, Hollingworth, Sam, Kisely, Steve, Gallagher, Erin, Hahn, Margaret, Ebdrup, Bjørn H, Firth, Joseph and Siskind, Dan (2019). Strategies to counter antipsychotic-associated weight gain in patients with schizophrenia. Expert Opinion on Drug Safety, 18 (12), 1-12. doi: 10.1080/14740338.2019.1674809 |
|
2019 Journal Article Ivabradine in patients with left-ventricular dysfunction and coronary artery diseasePham, Betty, Winckel, Karl and Snoswell, Centaine L. (2019). Ivabradine in patients with left-ventricular dysfunction and coronary artery disease. Pharmacy Growth, Research, Innovation and Training (Pharmacy GRIT), 3 (2), 131-132. |
|
2019 Journal Article Evaluation of weight based enoxaparin dosing on anti-Xa concentrations in patients with obesityvan Oosterom, Nameer, Winckel, Karl and Barras, Michael (2019). Evaluation of weight based enoxaparin dosing on anti-Xa concentrations in patients with obesity. Journal of Thrombosis and Thrombolysis, 48 (3), 387-393. doi: 10.1007/s11239-019-01847-4 |
|
2019 Journal Article An investigation into the relationship between clozapine treatment and cognitive performance in patients with treatment resistant schizophreniaMcArdle, P. A., De Mel, V., DeMonte, V., Winckel, K., Gore-Jones, V., Foley, S., Korman, N., Parker, S., Dark, F. and Siskind, D. (2019). An investigation into the relationship between clozapine treatment and cognitive performance in patients with treatment resistant schizophrenia. Schizophrenia Research, 206, 450-451. doi: 10.1016/j.schres.2018.11.030 |
|
2019 Journal Article Primary and secondary prevention of strokeBarras, M.A. and Winckel, K. (2019). Primary and secondary prevention of stroke. Australian Pharmacist, 12, 42-51. |
|
2019 Conference Publication The appropriateness of rivaroxaban drug level monitoring and the impact on clinical management in patientsMichael, Hayley, Hill, Courtney, Winckel, Karl and Norman Ilich (2019). The appropriateness of rivaroxaban drug level monitoring and the impact on clinical management in patients. SHPA mm2019, Gold Coast, Australia, 14-16 November 2019. |
|
2019 Conference Publication SGLT21-associated ketoacidosis a growing epidemic: a need for a consumer-friendly infographicLi, Catherine, Pinkerton, Eve and Winckel, Karl (2019). SGLT21-associated ketoacidosis a growing epidemic: a need for a consumer-friendly infographic. In: SHPA MM2019, Gold Coast, QLD Australia, (). 21-22 November 2019. |
|
2019 Conference Publication Evaluation of weight based enoxaparin dosing on anti-Xa concentrations in patients with obesityVan Oosterom, N., Barras, M. and Winckel, K. (2019). Evaluation of weight based enoxaparin dosing on anti-Xa concentrations in patients with obesity. Princess Alexandra Hospital (PAH) Health Symposium., Brisbane, QLD, Australia, 31 July 2019. |
|
2019 Conference Publication Final foundation residency portfolio reviews – Feedback from a two-site review processWoodruff, Gemma, Hendy, Anna, Coombes, Judith, Winckel, Karl, Hale, Andrew, Coombes, Ian and Barras, Michael (2019). Final foundation residency portfolio reviews – Feedback from a two-site review process. APSA 2019, Melbourne, Australia, 1-4 December 2019. |
|
2019 Conference Publication Dosing intravenous iron: keep it simpleVongphakdi, M., Winckel, K. and Sullivan, S. (2019). Dosing intravenous iron: keep it simple. SHPA mm2019, Gold Coast, QLD, Australia, 14-16 November 2019. |
|
2019 Conference Publication Assessing pharmacists adventures in the digital ageWaddell, Jason, House, Lee and Winckel, Karl (2019). Assessing pharmacists adventures in the digital age. In: SHPA MM2019, Gold Coast, QLD Australia, (). 21-22 November 2019. |
|
2019 Conference Publication The phosphate debate: intravenous vs OralEdmonds, M., Winckel, K., Cameron, C. and Powell, H. (2019). The phosphate debate: intravenous vs Oral. Princess Alexandra Hospital (PAH) Health Symposium, Princess Alexandra Hospital (PAH) Brisbane, 31 July 2019. |
|
2019 Conference Publication The ketone crisis. Drug use evaluation of SGLT2 inhibitors and ketoacidosisPinkerton, E., Winckel, K. and Forrester, T. (2019). The ketone crisis. Drug use evaluation of SGLT2 inhibitors and ketoacidosis. SHPA MM2019, Gold Coast, QLD Australia, 14-16 November 2019. |
|
2018 Journal Article Clozapine-related neutropenia, myocarditis and cardiomyopathy adverse event reports in Australia 1993-2014 (vol 235, pg 1915, 2018)Hollingworth, Samantha A., Winckel, Karl, Saiepour, Nargess, Wheeler, Amanda J., Myles, Nicholas and Siskind, Dan (2018). Clozapine-related neutropenia, myocarditis and cardiomyopathy adverse event reports in Australia 1993-2014 (vol 235, pg 1915, 2018). Psychopharmacology, 235 (7), 2193-2193. doi: 10.1007/s00213-018-4909-5 |
|
2018 Journal Article Clozapine-related neutropenia, myocarditis and cardiomyopathy adverse event reports in Australia 1993-2014Hollingworth, Samantha A., Winckel, Karl, Saiepour, Nargess, Wheeler, Amanda J., Myles, Nicholas and Siskind, Dan (2018). Clozapine-related neutropenia, myocarditis and cardiomyopathy adverse event reports in Australia 1993-2014. Psychopharmacology, 235 (7), 1915-1921. doi: 10.1007/s00213-018-4881-0 |
|
2018 Journal Article CoMET: a protocol for a randomised controlled trial of co-commencement of METformin as an adjunctive treatment to attenuate weight gain and metabolic syndrome in patients with schizophrenia newly commenced on clozapineSiskind, Dan, Friend, Nadia, Russell, Anthony, McGrath, John J., Lim, Carmen, Patterson, Sue, Flaws, Dylan, Stedman, Terry, Moudgil, Vikas, Sardinha, Savio, Suetani, Shuichi, Kisely, Steve, Winckel, Karl and Baker, Andrea (2018). CoMET: a protocol for a randomised controlled trial of co-commencement of METformin as an adjunctive treatment to attenuate weight gain and metabolic syndrome in patients with schizophrenia newly commenced on clozapine. BMJ Open, 8 (3) e021000, e021000. doi: 10.1136/bmjopen-2017-021000 |
|
2018 Conference Publication It's time to re-design safe prescribing education for digital hospitals!Cheng, Vesa , Forrester, Tori , Hill, Courtney , Slater, Theresa , Winckel, Karl and Coombes, Judith (2018). It's time to re-design safe prescribing education for digital hospitals!. SHPA Medicines Management 2018, Brisbane, Australia, 22-25 November 2018. |
|
2018 Conference Publication Treatment of clozapine-associated obesity and diabetes with exenatide (CODEX): a pilot randomised controlled trialSiskind, D., Mayfield, K., Winckel, K., Hollingworth, S. and Kisely, S. (2018). Treatment of clozapine-associated obesity and diabetes with exenatide (CODEX): a pilot randomised controlled trial. SHPA MM2019, Brisbane, Australia, 22-25 November 2019. |
|
2018 Conference Publication Dosing of Unfractionated Heparin in obese patients at the Princess Alexandra HospitalGeorge, C., Winckel, K., Barras, M., Coombes, J. and Cottrell, N. (2018). Dosing of Unfractionated Heparin in obese patients at the Princess Alexandra Hospital. Translational Research Institute Symposium, Brisbane, QLD, Australia, August 2018. |
|
2018 Conference Publication Treatment of clozapine-associated obesity and diabetes with exenatide (Codex) in adults with schizophrenia: a randomised controlled trialSiskind, Dan, Russell, Anthony, Gamble, Clare, Winckel, Karl, Hollingworth, Sam and Kisely, Steve (2018). Treatment of clozapine-associated obesity and diabetes with exenatide (Codex) in adults with schizophrenia: a randomised controlled trial. 6th Biennial Conference of the Schizophrenia International Research Society (SIRS), Florence, Italy, 4-8 April 2018. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/schbul/sby016.436 |
